Completed NA INTERVENTIONAL 3-arm NCT04222296

Bimodal, CROS and Severe Profound Hearing Loss Study

Clinical Evaluation of Outcomes With Hearing Aid Parameters Designed for Adults With Severe-profound Hearing Loss and Unilateral Cochlear Implants in Bimodal (Cochlear Implant and Contralateral Hearing Instrument), CROS (Contralateral Routing of Signals) and Bilateral Amplification Strategies

Sponsor: Advanced Bionics AG

Conditions Cochlear Implant Hearing Loss, Bilateral Hearing Loss, Cochlear Severe-Profound Hearing Loss

Interventions Fitting strategy of cohlear implant of hearing aid

Updated 5 times since 2020 Last updated: Jun 30, 2021 Started: Sep 4, 2018 Primary completion: Mar 1, 2021 Completion: Mar 1, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Cochlear Implant and Hearing Loss, Bilateral and is currently completed. Advanced Bionics AG leads this study, which shows 5 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2021 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Jan 2021 — Sep 2021 [monthly]

Recruiting NA
Feb 2020 — Jan 2021 [monthly]

Recruiting NA

First recorded

Sep 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Advanced Bionics AG
Cambridge University Hospitals NHS Foundation Trust

Data source: Cambridge University Hospitals NHS Foundation Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cambridge, United Kingdom